Literature DB >> 29441808

Individualized ablation strategy guided by live simultaneous global mapping to treat persistent atrial fibrillation.

Rui Shi1, Mark Norman1, Zhong Chen1, Tom Wong1.   

Abstract

Atrial fibrillation (AF) is the most common clinical arrhythmia encountered. Catheter ablation has become the first-line therapy for symptomatic drug-refractory paroxysmal and persistent AF. Although pulmonary vein electrical isolation is still the cornerstone of the ablation strategy, the clinical outcome particularly in treating persistent AF is suboptimal. Significant efforts have been applied with live global chamber mapping of AF aimed to identify patient-specific drivers and/or maintainers located outside of the pulmonary veins to further improve the outcome of catheter ablation. Within this review, we present an overview of contemporary global chamber AF mapping technologies and characteristics, with a particular focus on global, noncontact, dipole density mapping illustrated with a clinical case of persistent AF ablation using this novel methodology.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; dipole density noncontact mapping

Mesh:

Year:  2018        PMID: 29441808     DOI: 10.2217/fca-2017-0109

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  8 in total

Review 1.  Global Substrate Mapping and Targeted Ablation with Novel Gold-tip Catheter in De Novo Persistent AF.

Authors:  Michael Tb Pope; Timothy R Betts
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04

2.  Diverse activation patterns during persistent atrial fibrillation by noncontact charge-density mapping of human atrium.

Authors:  Rui Shi; Zhong Chen; Charlie Butcher; Junaid Ab Zaman; Vennela Boyalla; Yi Kan Wang; Omar Riad; Anitha Sathishkumar; Mark Norman; Shouvik Haldar; David G Jones; Wajid Hussain; Vias Markides; Tom Wong
Journal:  J Arrhythm       Date:  2020-05-20

3.  Localization of Right Ventricular Outflow Tract Premature Ventricular Complexes Using a Novel Mapping System.

Authors:  Mehmet Ali Elbey; Sri Harsha Kanuri; Naushad Shaikh; Rakesh Gopinathannair; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2021-04-30

4.  Novel noncontact charge density map in the setting of post-atrial fibrillation atrial tachycardias: first experience with the Acutus SuperMap Algorithm.

Authors:  Robbert Ramak; Gian-Battista Chierchia; Gaetano Paparella; Cinzia Monaco; Vincenzo Miraglia; Federico Cecchini; Antonio Bisignani; Joerelle Mojica; Maysam Al Housari; Dimitrios Sofianos; Shuichiro Kazawa; Ingrid Overeinder; Gezim Bala; Erwin Ströker; Juan Sieira; Thiago Guimaraes Osorio; Pedro Brugada; Carlo de Asmundis
Journal:  J Interv Card Electrophysiol       Date:  2020-07-08       Impact factor: 1.900

5.  Initial experience with AcQMap catheter for treatment of persistent atrial fibrillation and atypical atrial flutter.

Authors:  M Liebregts; M C E F Wijffels; M N Klaver; V F van Dijk; J C Balt; L V A Boersma
Journal:  Neth Heart J       Date:  2021-10-26       Impact factor: 2.854

6.  Clinical utility of non-contact charge density 'SuperMap' algorithm for the mapping and ablation of organized atrial arrhythmias.

Authors:  Michael T B Pope; Milena Leo; Andre Briosa E Gala; Timothy R Betts
Journal:  Europace       Date:  2022-05-03       Impact factor: 5.486

7.  Impact of Adenosine on Wavefront Propagation in Persistent Atrial Fibrillation: Insights From Global Noncontact Charge Density Mapping of the Left Atrium.

Authors:  Michael T B Pope; Pawel Kuklik; Andre Briosa E Gala; Milena Leo; Michael Mahmoudi; John Paisey; Timothy R Betts
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

8.  Spatial and temporal variability of rotational, focal, and irregular activity: Practical implications for mapping of atrial fibrillation.

Authors:  Michael Tb Pope; Pawel Kuklik; Andre Briosa E Gala; Milena Leo; Michael Mahmoudi; John Paisey; Timothy R Betts
Journal:  J Cardiovasc Electrophysiol       Date:  2021-07-28       Impact factor: 2.942

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.